Pancreatic Cancer Basics
597 articles
Meet the Researcher: Arnav Mehta, M.D., Ph.D.
Dr. Arnav Mehta combines mathematics and medicine in his search to improve options for gastrointestinal cancer patients. Learn about his groundbreaking work.
When Certain Chemotherapy Drugs Are in Short Supply
It’s been all over the news–some chemotherapy drugs are in short supply. Dr. Allyson Ocean explains a doctor’s options in these situations.
Advances in Treatment Give Me Hope
Candace Langford’s honeymoon was hardly over when she found out she had pancreatic cancer. Fortunately she was able to have stereotactic body radiation therapy, which has knocked out her tumor.
Two-Drug Combo Targets KRAS and Fights Resistance
Researcher Hervé Tiriac leads a clinical trial for a new drug combination targeting KRAS and chemotherapy resistance.
Slowing the Growth of One Type of Advanced Neuroendocrine Tumor
Dr. Kelsey Klute explains the advantages of the radiopharmaceutical lutetium Lu 177 dotatate treatment for certain neuroendocrine tumors.
Can SBRT Become More Effective?
Radiation oncologist Dr. Todd Aguilera is looking for ways to make SBRT a more effective treatment for pancreatic cancer.
Helping Some Types of Chemotherapy Penetrate Pancreatic Tumors
A clinical trial looks at the effectiveness of PEGPH20 in helping chemotherapy penetrate the stroma of pancreatic tumors, to make them removable.
Testing a New Drug on Advanced Pancreatic Neuroendocrine Tumors
In a clinical trial, the new drug sapanisertib is being tested for its effectiveness against pancreatic neuroendocrine tumors (PNETs).
Let’s Win Pancreatic Cancer Survivors Series—Year Six
Join Let’s Win’s long-term survivors as they share their uplifting stories of treatment, resilience, and life after pancreatic cancer.
With No Family History of Cancer, Surprised By the Diagnosis
Marianne, a nurse, went to a hospital that specializes in cancer. A liquid biopsy will determine the next step in her treatment.
Tougher Than Cancer
Not even Hurricane Harvey could stop Kayi Lewis from getting the radiation treatment she needed as she battled pancreatic cancer.
Testing a PARP Inhibitor for Metastatic Pancreatic Cancer Patients with DNA Repair Mutations
Researchers are testing a PARP inhibitor that is effective for cancers in pancreatic cancer patients with DNA repair mutations.
BRCA Mutation Determines My Pancreatic Cancer Treatment
Chris Treubert started with one type of chemotherapy but when the results of genetic testing showed a BRCA mutation he changed treatment.
More Effective Radiotherapy for Advanced Pancreatic Cancer Patients
Researchers are testing a drug that penetrates the stroma, to make radiotherapy work better for advanced pancreatic cancer patients.
What Happens When Pancreatic Cancer Clinical Trials Fail?
Why do clinical trials fail? What about the patients on the trial? Learn more about what happens when pancreatic cancer clinical trials fail.